|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/165 | (2006.01) |
| A61P 25/28 | (2006.01) |
| (11) | Number of the document | 2029130 |
| (13) | Kind of document | T |
| (96) | European patent application number | 07725989.3 |
| Date of filing the European patent application | 2007-06-13 | |
| (97) | Date of publication of the European application | 2009-03-04 |
| (45) | Date of publication and mention of the grant of the patent | 2015-08-19 |
| (46) | Date of publication of the claims translation | 2015-11-25 |
| (86) | Number | PCT/EP2007/005197 |
| Date | 2007-06-13 |
| (87) | Number | WO 2007/144153 |
| Date | 2007-12-21 |
| (30) | Number | Date | Country code |
| 06012352 | 2006-06-15 | EP |
| (72) |
SALVATI, Patricia, IT
ROSSETTI, Stefano, IT
BENATTI, Luca, IT
|
| (73) |
Newron Pharmaceuticals S.p.A.,
Via L. Ariosto, 21, 20091 Bresso (MI),
IT
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Alfa-aminoamidų dariniai, naudingi pažinimo sutrikimų gydymui |
| ALPHA-AMINOAMIDE DERIVATIVES USEFUL IN THE TREATMENT OF COGNITIVE DISORDERS |
| Payment date | Validity (years) | Amount | |
| 2025-05-20 | 19 | 347.00 EUR |
| 2026-06-13 |